期刊文献+

组织芯片技术在胃癌p53蛋白表达研究中的应用 被引量:3

The Study of Expression of p53 and Its Signification in Gastric Adenocarcinoma Using Tissue Microarrays
下载PDF
导出
摘要 目的探讨组织芯片免疫组化标记结果的可靠性,研究p53表达与胃癌临床病理特征及预后的相关性。方法将100例无术前放化疗史的胃癌手术标本和30例对照组胃粘膜制成组织芯片后,用免疫组化方法分别在组织芯片和常规切片上检测p53蛋白的表达,比较其差异;用TUNEL法进行细胞凋亡指数检测。对随访14个月至13年的47例作生存分析。结果共获得2个组织芯片蜡块。p53检测在常规切片和组织芯片同为阳性或同为阴性者占98%,不一致者占2%。p53表达在胃癌不同组织学分化、UICC分期和血管/神经侵犯、淋巴结转移中均有差异,但无统计学意义(P>0.05)。p53表达与细胞凋亡指数呈负相关,但差异无统计学意义(P>0.05)。随访结果生存分析显示,p53表达与预后无关,UICC分期具有独立的预后意义。结论组织芯片和常规切片免疫组化结果有较好的一致性。组织芯片技术是病理学研究中的高效、快速工具。p53表达与胃癌预后无显著相关性,UICC分期仍然是胃癌的独立预后指标。 Objective To explore the credibility of expression of p53 in gastric carcinoma by using tissue microarrys compared with those by using conventional technique. And relationship between p53 expression and the clinicopathologic features and prognosis of gastric carcinoma was also studied. Methods The gastric cancer tissue microarrays were composed of those from 100 cases of adenocarcinoma of the stomach without a history of chemo-radiation therapy and 30 gastric tissues of control subject. p53 expression was investigated immunohistochemically in the tissue microarrys and in conventional sections. The difference of these subjects was analyzed. Tumor cell apoptosis was also examined by TUNEL method. Of the 100 cases, 47cases were followed-up from 14 months to 13 years, in which the prognosis was analyzed. Results Two paraffin-embedded gastric carcinoma tissue microarrays were successfully constructed. Immunohistochemical analysis showed that p53 expression which was identical accounted for 98 % in the tissuechips and in the conventional section. The p53 expression was associated with histological grades, invading of vessel & nerve, lymph node involvement, UICC stages and AI, but the difference was not significant. The followed-up data analysis showed that the survival rate was correlated with UICC staging but unrelated to p53. Conclusions Tissue microarray technique is a credible and useful method for pathologic research, p53 expression is unrelated to prognosis in gastric carcinoma. UICC staging retained significant independently in prospecting prognosis.
出处 《苏州大学学报(医学版)》 CAS 北大核心 2005年第5期816-821,共6页 Suzhou University Journal of Medical Science
关键词 胃癌 组织芯片 细胞凋亡 P53蛋白 gastric carcinoma tissue microarray apoptosis p53 protein
  • 相关文献

参考文献11

  • 1Kononen J, Bubendor L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens[J]. Nat Med, 1998, 4(7)∶844-847.
  • 2Kallioniemi OP, Wagner U, Kononen J, et al. Tissue microarray technology for high-throughput molecular profiling of cancer[J]. Hum Mol Genet, 2001, 10(7)∶657-662.
  • 3周小鸽,张劲松,张小平,张野,Kristian Sandvej,Stephen J Hamilton-Dutoit.组织芯片[J].中华病理学杂志,2002,31(1):70-72. 被引量:85
  • 4朱明华.组织微阵列及其在肿瘤病理研究中的应用[J].中华病理学杂志,2002,31(1):72-74. 被引量:26
  • 5Lu CD, Altieri DC, Tanigawa N. Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas[J]. Cancer Res, 1998, 58(9)∶1808-1812.
  • 6Fernebro E, Dictor M, Bendahl PO, et al. Evaluation of the tissue microarray technique for immunohistochemical analysis in rectal cancer[J]. Arch Pathol Lab Med, 2002,126(6)∶702-705.
  • 7Ikeguchi M, Tatebe s, Kaibara N, et al. Changes in levels of expression of p53 and the product of the bcl-2 in lines of gastric cancer cells during cisplatin-induced apoptosis[J].Eur Surg Res, 1997;29(5)∶396-402.
  • 8杨其昌,韩枋,何松,张建兵,陶玉,朱惠君,曹松.免疫组织化学标记对结直肠癌活检漏诊标本的诊断价值[J].中华消化内镜杂志,1999,16(3):171-172. 被引量:1
  • 9Tannapfel A, Schmelzer S, Benicke M, et al. Expression of the p53 homologues p63 and p73 in multiple simultanous gastric cancer[J]. J Pathol, 2001, 195(2)∶163-170.
  • 10Starzynska T, Markiewski M, Domagala W, et al.The clinical significance of p53 accumulation in gastric carcinoma[J].Cancer,1996,77(10)∶2005-2012.

二级参考文献31

共引文献105

同被引文献29

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1368
  • 2杨宣琴,王全红,焦士兰,龚方纯.食管鳞癌中P53和CD44V6的表达与淋巴结转移的关系[J].实用医技杂志,2004,11(12A):2496-2498. 被引量:2
  • 3Clary BM, DeMatteo RP, Lewis JJ, et al. Gastrointestinal stromal tumors and leiomyosarcoma of the abdomen and retroperitoneum : a clinical comparison [ J ]. Ann Surg Oncol, 2001,8 : 290 - 299.
  • 4Lachat Y, Diserens AC, Nozaki M, et al. INK4a/Arf is required for suppression of EGFR/DeltaEGFR ( 2 - 7 )-dependent ERK activation in mouse astrocytes and glioma[ J]. Oncogene, 2004,23 (41) : 6854 - 6863.
  • 5Boucher M J, Jean D, Vezina A, et al. Dual role of MEK/ ERK signalling in senescence and transformation of intestinal epithelial cells [ J ]. Am J Physiol Gastrointest Liver Physiol, 2004,286(5) : G736 -746.
  • 6Mittincn M, Sobin LH, Lasota J, et al. Gastrointestinal stromal tumors of stomach: a clinicopathologic, immunohistochemical and molecular genetic study of 1765 cases with long-term follow-up[J]. AM J Surg Pathol, 2005,29:52-68.
  • 7Danielle AM, Sosina M, Wiem L, et al. Inhibition of Tumor Endothelial ERK Activation, Angiogenesis, and Tumor Growth by Sorafenib [J]. Am J Pathol, 2006, 169: 1875 - 1885.
  • 8Barbera VM,Martin M,Marinoso L,et al.The 18q21 region in coloreclal and pancreatic cancer.independent loss of DCC and DP4 expression[J].Biochim Biophys Acta,2000,1502(2):283-296.
  • 9Xiangming C,Natsugoe S,Takao S,et al.Preserved Smad4 expression in the transforming growth factor in patients with advanced gastric cancer[J].Clin Cancer Bes,2001,7 (2):277-282.
  • 10Kim JY,Park DY,Kim GH,et al.Smad4 expression in gastric adenoma and adenocarcinoma:frequent loss of expression in diffuse type of gastric adenocarcinoma[J].Histoi Histopathol,2005,20(2):543-549.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部